Press Release: "Memeron Alzheimer's Drug Offers Hope to Patients and Caregivers"
Galantamine is derived from the flowers and bulbs of the Caucasian snowdrop (Galanthus nivalis), Red Spider Lily (Lycoris radiata), and related species of plants. Galantamine is proven to be a superb naturally based medicine in the treatment of memory deficits and cognitive decline. Galantamine was originally discovered by a Bulgarian pharmacologist in the 1950's and has since been used to treat mild to moderate cases of Alzheimer's disease and vascular dementia. Since the original discovery of Galantamine's neurological benefits, researchers have learned that Galantamine is a cholinesterase inhibitor that increases the levels of active acetylcholine levels in the brain. Decreased levels of the neurotransmitter acetylcholine have been correlated with memory deficits and Alzheimer-type symptoms. Galantamine effectively utilizes acetylcholine in the brain to maintain healthy levels critical to memory and normal cognitive functioning. Recent research has also indicated that cholinesterase inhibitors such as Galantamine are most effective when taken in conjunction with a strong acetylcholine precursor. Memeron™ utilizes Alpha GPC (choline alfoscerate) as a nourishing choline source that rapidly crosses the blood-brain barrier to help produce additional acetylcholine for memory functions. The unique balance offered by Memeron™ ensures the brain is getting sufficient neurotransmitters and essential nutrients for sustained mental clarity.
FDA Notice: Galantamine is FDA approved to treat mild to moderate Alzheimer's disease. Galantamine is well-tolerated and has been studied extensively for over 50 years. Mild stomach irritation may occur if taken without meals. Please consult with a physician if symptoms worsen or if any health conditions arise while using Memeron™. |
Patent Pending. Patent application filed with US Patent and Trademark Office. Patent application number: 61074264
© 2008 Distributed by CerebralHealth.com